| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |